219 related articles for article (PubMed ID: 15150565)
21. Diagnostic Dilemma: Carcinoid Syndrome.
Beri N; Farid A; Galkin M; Lewis W; Amsterdam E
Am J Med; 2018 Oct; 131(10):e405-e407. PubMed ID: 29906424
[No Abstract] [Full Text] [Related]
22. [Tricuspid insufficiency disclosing carcinoid syndrome].
Monségu J; Algayres JP; Ciribilli JM; Bussière JL; Duriez P; Gaillard JF; Daly JP
Rev Med Interne; 1994; 15(9):593-6. PubMed ID: 7984839
[TBL] [Abstract][Full Text] [Related]
23. [Echocardiographic detection of tricuspid insufficiency in carcinoid heart syndrome - case report].
Polster J; Klapdor R; Langenstein BA; Hanrath P
Z Kardiol; 1982 Oct; 71(10):689-90. PubMed ID: 7157923
[TBL] [Abstract][Full Text] [Related]
24. [Isolated carcinoid tumor of the ovary disclosed by tricuspid insufficiency].
Nallet O; Nahon S; Cormier B; Cadoux L; Iung B; Mazouz S; Vitaux F; Richemond J; Couetil JP; Sergent J
Arch Mal Coeur Vaiss; 2003 Feb; 96(2):144-8. PubMed ID: 14626739
[TBL] [Abstract][Full Text] [Related]
25. [Atypical presentation of a carcinoid syndrome].
Sirois I; Pothier J; Couture C; Bolduc P
Can J Cardiol; 1999 Apr; 15(4):469-71. PubMed ID: 10322257
[TBL] [Abstract][Full Text] [Related]
26. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease.
Davutoglu V; Celik A; Aksoy M; Sezen Y; Soydinc S; Gunay N
Eur J Heart Fail; 2005 Jun; 7(4):532-6. PubMed ID: 15921791
[TBL] [Abstract][Full Text] [Related]
27. [Abnormal tricuspid flow in carcinoid heart disease. A case report].
Selton-Suty C; Juillière Y; Anconina J; Danchin N; Isaaz K; Henneton C; Conroy T; Cherrier F
Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1863-6. PubMed ID: 2125198
[TBL] [Abstract][Full Text] [Related]
28. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
[TBL] [Abstract][Full Text] [Related]
29. The tricuspid valve in carcinoid syndrome. An echocardiographic study.
Taber M; Askenazi J; Ribner H; Kumar S; Lesch M
Arch Intern Med; 1983 May; 143(5):1033-4. PubMed ID: 6206810
[TBL] [Abstract][Full Text] [Related]
30. [Natriuretic peptides--new diagnostic markers in heart disease].
Angermann CE; Ertl G
Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
[TBL] [Abstract][Full Text] [Related]
31. Update in carcinoid heart disease - the heart of the matter.
Oleinikov K; Korach A; Planer D; Gilon D; Grozinsky-Glasberg S
Rev Endocr Metab Disord; 2021 Sep; 22(3):553-561. PubMed ID: 33443717
[TBL] [Abstract][Full Text] [Related]
32. Ovarian strumal carcinoid tumor responsible for carcinoid heart disease.
Brunaud L; Antunes L; Sebbag H; Bresler L; Villemot JP; Boissel P
Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):124-6. PubMed ID: 11516812
[TBL] [Abstract][Full Text] [Related]
33. Incidence and evolution of carcinoid syndrome in the heart.
Moyssakis IE; Rallidis LS; Guida GF; Nihoyannopoulos PI
J Heart Valve Dis; 1997 Nov; 6(6):625-30. PubMed ID: 9427132
[TBL] [Abstract][Full Text] [Related]
34. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions.
Kolditz M; Halank M; Schiemanck CS; Schmeisser A; Höffken G
Eur Respir J; 2006 Jul; 28(1):144-50. PubMed ID: 16481382
[TBL] [Abstract][Full Text] [Related]
35. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
[TBL] [Abstract][Full Text] [Related]
36. Evidence for rheumatic valve disease in patients with severe tricuspid regurgitation long after mitral valve surgery: the role of 3D echo reconstruction.
Henein MY; O'Sullivan CA; Li W; Sheppard M; Ho Y; Pepper J; Gibson DG
J Heart Valve Dis; 2003 Sep; 12(5):566-72. PubMed ID: 14565707
[TBL] [Abstract][Full Text] [Related]
37. Baseline natriuretic peptide levels in relation to myocardial ischemia, troponin T release and heart rate variability in patients undergoing major vascular surgery.
Feringa HH; Vidakovic R; Karagiannis SE; de Jonge R; Lindemans J; Goei D; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2007 Dec; 18(8):645-51. PubMed ID: 18004116
[TBL] [Abstract][Full Text] [Related]
38. [Heart involvement in carcinoid syndrome].
Grollier G; Huret B; Commeau P; Potier JC
Presse Med; 1986 Sep; 15(28):1323-5. PubMed ID: 2950393
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
Brueckmann M; Huhle G; Lang S; Haase KK; Bertsch T; Weiss C; Kaden JJ; Putensen C; Borggrefe M; Hoffmann U
Circulation; 2005 Jul; 112(4):527-34. PubMed ID: 16027260
[TBL] [Abstract][Full Text] [Related]
40. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study.
Januzzi JL; Morss A; Tung R; Pino R; Fifer MA; Thompson BT; Lee-Lewandrowski E
Crit Care; 2006 Feb; 10(1):R37. PubMed ID: 16507171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
